PT  - JOURNAL ARTICLE
AU  - Hicks, Emily M.
AU  - Niarchou, Maria
AU  - Goleva, Slavina
AU  - Kabir, Dia
AU  - Ciarcia, Julia
AU - PTSD & Trauma EHR Working Group
AU  - Smoller, Jordan W.
AU  - Davis, Lea K.
AU  - Nievergelt, Caroline M.
AU  - Koenen, Karestan C.
AU  - Huckins, Laura M.
AU  - Choi, Karmel W.
TI  - Comorbidity Profiles of Posttraumatic Stress Disorder Across the Medical Phenome
AID  - 10.1101/2023.08.25.23294572
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.25.23294572
4099  - http://medrxiv.org/content/early/2023/08/28/2023.08.25.23294572.short
4100  - http://medrxiv.org/content/early/2023/08/28/2023.08.25.23294572.full
AB  - Background Prior epidemiological research has linked PTSD with specific physical health problems, but the comprehensive landscape of medical conditions associated with PTSD remains uncharacterized. Electronic health records (EHR) provide an opportunity to overcome prior clinical knowledge gaps and uncover associations with biological relevance that potentially vary by sex.Methods PTSD was defined among biobank participants (total N=123,365) in a major healthcare system using two ICD code-based definitions: broad (1+ PTSD or acute stress codes versus 0; NCase=14,899) and narrow (2+ PTSD codes versus 0; NCase=3,026). Using a phenome-wide association (PheWAS) design, we tested associations between each PTSD definition and all prevalent disease umbrella categories, i.e., phecodes. We also conducted sex-stratified PheWAS analyses including a sex-by-diagnosis interaction term in each logistic regression.Results A substantial number of phecodes were significantly associated with PTSDNarrow (61%) and PTSDBroad (83%). While top associations were shared between the two definitions, PTSDBroad captured 334 additional phecodes not significantly associated with PTSDNarrow and exhibited a wider range of significantly associated phecodes across various categories, including respiratory, genitourinary, and circulatory conditions. Sex differences were observed, in that PTSDBroad was more strongly associated with osteoporosis, respiratory failure, hemorrhage, and pulmonary heart disease among male patients, and with urinary tract infection, acute pharyngitis, respiratory infections, and overweight among female patients.Conclusions This study provides valuable insights into a diverse range of comorbidities associated with PTSD, including both known and novel associations, while highlighting the influence of sex differences and the impact of defining PTSD using EHR.Competing Interest StatementDisclosures: JWS is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received grant support from Biogen, Inc. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments.Funding StatementThis collaborative work was supported in part by the PsycheMERGE grant MH118233 (to JWS and LKD) and administrative supplement to PGC PTSD R01 (R01MH106595). KWC was supported in part by funding from the National Institute of Mental Health (K08MH127413) and a NARSAD Brain and Behavior Foundation Young Investigator Award. EMH, JC and LMH acknowledge funding from NIMH (R01MH124839, R01MH118278) and NIEHS (R01ES033630). LKD was supported by NIMH (R01MH118223); NHGRI and the Office of Research on Womens Health (RM1HG009034). MSSM: This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai under award number S10OD018522 from the Office of Research Infrastructure of the National Institutes of Health. This work was supported through the resources and staff expertise provided by the Charles Bronfman Institute for Personalized Medicine and the BioMe Biobank Program at the Icahn School of Medicine at Mount Sinai. BioVU: The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by numerous sources: institutional funding, private agencies, and federal grants. These include the NIH funded Shared Instrumentation Grant S10RR025141; and CTSA grants UL1TR002243, UL1TR000445, and UL1RR024975. Genomic data are also supported by investigator-led projects that include U01HG004798, R01NS032830, RC2GM092618, P50GM115305, U01HG006378, U19HL065962, R01HD074711; and additional funding sources listed at https://victr.vumc.org/biovu-funding/. This publication was supported by Grant No. R01 HG011405, partially funded by the Office of Research on Women's Health, Office of the Director, NIH and the National Human Genome Research Institute. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Office of Research on Womens Health or the National Human Genome Research Institute. Disclosures: JWS is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity), and has received grant support from Biogen, Inc. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Vanderbilt University Medical Center gave ethical approval for this work (#190418). IRB of Mount Sinai School of Medicine gave ethical approval for this work (#07-0529). IRB of Mass General Brigham gave ethical approval for this work (#2018P002642)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript and supplemental materials.